SynBiotic SE (ETR:SBX)
1.184
-0.046 (-3.74%)
Jul 20, 2026, 5:35 PM CET
SynBiotic SE Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0 | 0.54 | 0.09 | 0.97 | 3.2 | 5.99 |
Cash & Short-Term Investments | 0 | 0.54 | 0.09 | 0.97 | 3.2 | 5.99 |
Cash Growth | -97.44% | 508.86% | -90.77% | -69.81% | -46.55% | 45111.44% |
Accounts Receivable | - | 0.98 | 0.48 | 0.31 | 0.73 | 0.88 |
Other Receivables | 11.99 | - | - | - | - | - |
Total Trade Receivables | 11.99 | 0.98 | 0.48 | 0.31 | 0.73 | 0.88 |
Inventory | - | 2.93 | 2.83 | 3.35 | 3.42 | 0.52 |
Other Current Assets | 1.1 | 0.03 | 0.08 | 3.43 | 3.23 | 0.29 |
Total Current Assets | 13.09 | 6.87 | 6.53 | 8.05 | 10.59 | 7.69 |
Net Property, Plant & Equipment | 0 | 5.02 | 4.89 | 5.42 | 5.86 | 0.02 |
Other Intangible Assets | 3.78 | 31.25 | 22.97 | 26.98 | 42.82 | 26.63 |
Long-Term Investments | 31.89 | 0 | 0.01 | 0.01 | 0.23 | 0.68 |
Other Long-Term Assets | - | 2.57 | 0.53 | 0.17 | 1.15 | 0 |
Total Assets | 48.77 | 45.71 | 34.92 | 40.62 | 60.65 | 35.03 |
Accounts Payable | 3.95 | 6.32 | 2.36 | 1.97 | 2.21 | 0.67 |
Accrued Expenses | 2.5 | - | - | - | - | 0 |
Current Portion of Long-Term Debt | - | 0.52 | 0.6 | 0.66 | 0.01 | 0.11 |
Other Current Liabilities | 3.63 | 8.62 | 5.06 | 3.11 | 2.75 | 8.42 |
Total Current Liabilities | 10.09 | 15.45 | 8.02 | 5.74 | 4.97 | 9.21 |
Long-Term Debt | 3.01 | 1.48 | 2.56 | 3.08 | 2.49 | 0.25 |
Other Long-Term Liabilities | - | 7.77 | 9.01 | 9.02 | 16.46 | 0.07 |
Total Long-Term Liabilities | 3.01 | 9.25 | 11.57 | 12.09 | 18.95 | 0.32 |
Total Liabilities | 10.6 | 24.7 | 19.59 | 17.83 | 23.92 | 9.53 |
Common Stock | 6.82 | 6.82 | 5 | 4.52 | 3.67 | 2.63 |
Additional Paid-in Capital | 79.37 | 74.41 | 59.4 | 56.06 | 44.94 | 23.75 |
Retained Earnings | -50.52 | -58.37 | -48.61 | -37.98 | -13.61 | -0.89 |
Total Common Shareholders' Equity | 35.67 | 22.87 | 15.79 | 22.59 | 35 | 25.49 |
Minority Interest | - | -1.86 | -0.46 | 0.2 | 1.72 | 0.01 |
Shareholders' Equity | 35.67 | 21.01 | 15.33 | 22.79 | 36.72 | 25.5 |
Total Liabilities & Equity | 48.77 | 45.71 | 34.92 | 40.62 | 60.65 | 35.03 |
Total Debt | 3.01 | 2 | 3.16 | 3.74 | 2.5 | 0.37 |
Net Cash (Debt) | -3.01 | -1.45 | -3.07 | -2.77 | 0.71 | 5.62 |
Net Cash Growth | - | - | - | - | -87.46% | 42342.36% |
Net Cash Per Share | -0.63 | -0.25 | -0.65 | -0.68 | 0.23 | 3.60 |
Book Value | 35.67 | 22.87 | 15.79 | 22.59 | 35 | 25.49 |
Book Value Per Share | 7.51 | 3.91 | 3.32 | 5.54 | 11.41 | 16.32 |
Tangible Book Value | 31.89 | -8.38 | -7.18 | -4.39 | -7.82 | -1.15 |
Tangible Book Value Per Share | 6.71 | -1.43 | -1.51 | -1.07 | -2.55 | -0.74 |